Sorry, you need to enable JavaScript to visit this website.

Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.

Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.

Sign-up to receive all GMG announcements, including Request for Proposal (RFP) postings.

Sign Up for Alerts
Title
Grant Type Sort ascending
Focus Area
Country
Application Due Date
Real World Evidence of Abrocitinib in Adolescent Patients with Moderate-to-Severe Atopic Dermatitis
Release Date:
Review Process: Pfizer Internal
Research Inflammation & Immunology China
The Value of Standardized Diagnosis and Treatment in Patients with Moderate-to-Severe Atopic Dermatitis
Release Date:
Review Process: Pfizer Internal
Research Inflammation & Immunology China
Cancer Registry
Release Date:
Review Process: Pfizer Internal
Translation: French (link)
Research Oncology Congo, The Democratic Republic
Projects for Enhancing Regional Cancer Treatment
Release Date:
Partner: Japanese Society of Clinical Oncology
Review Process: Expert Review Panel
Translation: Japanese (link)
Quality Improvement Oncology Japan
Quality Improvement Grants to improve the early suspicion, identification, and the management of patients with ATTR-CM
Release Date:
Review Process: Expert Review Panel
Translation: French (link)
Quality Improvement Rare Disease Canada
Quality Improvement Grants to Support Development of Cardiac Amyloid Centers
Release Date:
Review Process: Pfizer Internal
Quality Improvement Rare Disease USA
Reducing Barriers to Optimal Clinical Care in Breast Cancer
Release Date:
Review Process: Pfizer Internal
Quality Improvement Oncology Spain
Sickle Cell Disease (SCD) Fellowship
Release Date:
Review Process: Expert Review Panel
Fellowship Rare Disease USA
Transthyretin Cardiac Amyloidosis Fellowship
Release Date:
Review Process: Expert Review Panel
Fellowship Rare Disease USA
Develop Young Physicians to Lead the Increase in Preventive Awareness by Vaccination
Release Date:
Review Process: Pfizer Internal
Translation: Japanese (link)
Education Vaccines Japan
Title
Grant Type Sort ascending
Focus Area
Country
Application Due Date
ASTRO-Myovant Sciences-Pfizer Alliance New Combination Therapy Challenge
Release Date:
Partner: ASTRO and Myovant Sciences
Review Process: Expert Review Panel
Research Oncology USA
Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Research in Canada
Release Date:
Review Process: Pfizer Internal
Research Rare Disease Canada
Acromegaly Research- United States
Release Date:
Review Process: Pfizer Internal
Research Rare Disease USA
Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Research
Release Date:
Review Process: Pfizer Internal
Research Rare Disease USA
Quantifying the Socio-Economic Burden of Disease for Dermatology Patients and Caregivers
Release Date:
Review Process: Pfizer Internal
Research Inflammation & Immunology Argentina, Australia, Austria, Belgium, Brazil, Canada, Czech Republic, Denmark, Finland, France, Germany, Greece, Ireland, Israel, Italy, Japan, Korea, Netherlands, Norway, Poland, Portugal, Romania, Russia, Slovakia (Slovak Republic), Spain, Sweden, Switzerland, Turkey, United Kingdom
RWD in the management of MDR BacteRial severe InfEctions and invasive Fungal disease, ITalian experiences
Release Date:
Review Process: Expert Review Panel
Research Hospital Italy
Hereditary Transthyretin Amyloidosis Research in China
Release Date:
Review Process: Pfizer Internal
Research Rare Disease China
COVID-19 Vaccine Development for LMICs
Release Date:
Review Process: Pfizer Internal
Research Vaccines All
Pre-clinical and Translational Research in Multiple Myeloma
Release Date:
Review Process: Pfizer Internal
Research Oncology Italy
Global ATTR Amyloidosis Research
Release Date:
Review Process: Expert Review Panel
Research Rare Disease All
2022 Rheumatology Competitive Grant Program
Release Date:
Review Process: Expert Review Panel
Research Inflammation & Immunology USA
Inflammatory and Immune-Mediated Dermatologic Disorders Research RFP: Early Career Investigators
Release Date:
Review Process: Expert Review Panel
Research Inflammation & Immunology USA